Prevagen Dietary Supplement
January 2020: A federal judge adopted a magistrate judge’s October 2019 Report and Recommendation and denied Quincy Bioscience’s motion to dismiss.
October 2019: A magistrate judge recommended that the court deny the company’s motion to dismiss. Click here to read the decision.
February 2019: A class-action lawsuit was filed against Quincy Bioscience for allegedly falsely marketing that the dietary supplement Prevagen will “improve memory” and support a “sharper mind,” “clearer thinking,” and “healthy brain function” when, according to plaintiffs, the supplement does not improve memory and has no effect on the brain. (Plaintiffs amended their complaint in May 2019.) (Engert et al v. Quincy Bioscience, LLC, Case No. 19-cv-183, W. D. Tex.)
For more of TINA.org’s coverage of Prevagen, click here.